Profiel
David Nakasone is Senior Director-Investor Relations at Tarsus Pharmaceuticals, Inc. since 2021.
Formerly, Mr. Nakasone was Director-Investor Relations at Lineage Cell Therapeutics, Inc., Associate Director-Investor Relations at Ionis Pharmaceuticals, Inc., and Investor Relations Contact at Allergan, Inc. from 2013 to 2015.
Education includes undergraduate studies at San Diego State University.
Actieve functies van David Nakasone
| Bedrijven | Functie | Begin |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Investor Relations Contact | 01-09-2021 |
Eerdere bekende functies van David Nakasone
| Bedrijven | Functie | Einde |
|---|---|---|
| ALLERGAN, INC. | Public Communications Contact | 01-06-2015 |
| IONIS PHARMACEUTICALS, INC. | Public Communications Contact | - |
| LINEAGE CELL THERAPEUTICS, INC. | Investor Relations Contact | - |
Opleiding van David Nakasone
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
San Diego State University
San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapeutic drugs for blepharitis | Health Technology |
















